Home›People›Dan Fisher
DF

Dan Fisher

Director at Marrow Access Technologies.

ExecutiveDirector
Updated Nov 10, 2026·Latest SEC filing Apr 9, 2026·Suggest an edit

About Dan Fisher

Dan Fisher is a director at Marrow Access Technologies.

Dan Fisher first appears on SEC filings in 2018.

Experience

This experience comes from Dan Fisher's profile and from SEC filings. For roles taken from filings, the years are when the filings name Dan Fisher in the role, so the role may have started earlier or lasted longer.

Stride Robotics Current
Vice President of Business Development
2025 – Present
Marrow Access Technologies, Inc. Current
Co-Founder, Board Member, VP of Corporate Development
2015 – Present · Eden Prairie, MN
Marrow access devices for surgeons treating patients with cartilage defects.
Strategic Pharmaceutical Solutions Current
Owner
2003 – Present
Ablation Safety Technologies
Co-Founder, Board Member, COO
2019 – 2020
Livio Health Group
Co-Founder and VP of Business Development (SOLD TO BCBS)
2015 – 2016
University of Minnesota’s Medical Devices Center
Business Advisor
2015 – 2016
St. Teresa Medical
Co-Founder and VP Marketing & Sales
2010 – 2015
Apjohn Group
Member
2007 – 2012
Upsher-Smith Laboratories
Director of Business Development
2000 – 2003
Express Scripts
Sr Product Director
1997 – 2000
Eli Lilly
MCO manager
1983 – 1997

Key Colleagues at Startups

The people Dan Fisher works with at each company, as listed on that company's latest Form D.

Marrow Access Technologies, Inc. · Form D, Apr 9, 2026
JK
Jason Koh
Executive officer and director
PV
JS
Joseph Saladino
CEO and director
KF
Kevin Foley
Director
JC
Jim Cloar
Director

Sources

  1. SECMarrow Access Technologies, Inc. Form D, filed Apr 9, 2026